The European Journal of Health Economics最新文献

{"title":"Projected costs of informal care for older people in England","authors":"Bo Hu, Javiera Cartagena-Farias, Nicola Brimblecombe, Shari Jadoolal, Raphael Wittenberg","doi":"10.1007/s10198-023-01643-1","DOIUrl":"https://doi.org/10.1007/s10198-023-01643-1","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Background</h3><p>Health economics research and economic evaluation have increasingly taken a societal perspective, accounting for the economic impacts of informal care. Projected economic costs of informal care help researchers and policymakers understand better the long-term consequences of policy reforms and health interventions. This study makes projections of the economic costs of informal care for older people in England.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>Data come from two national surveys: the English Longitudinal Study of Ageing (ELSA, <i>N</i> = 35,425) and the Health Survey for England (<i>N</i> = 17,292). We combine a Markov model with a macrosimulation model to make the projections. We explore a range of assumptions about future demographic and epidemiological trends to capture model uncertainty and take a Bayesian approach to capture parameter uncertainty.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>We estimate that the economic costs of informal care were £54.2 billion in 2019, three times larger than the expenditure on formal long-term care. Those costs are projected to rise by 87% by 2039, faster than public expenditure but slower than private expenditure on formal long-term care. These results are sensitive to assumptions about future life expectancy, fertility rates, and progression of disabilities in the population.</p><h3 data-test=\"abstract-sub-heading\">Conclusions</h3><p>Prevention schemes aiming to promote healthy aging and independence will be important to alleviate the costs of informal care. The government should strengthen support for informal caregivers and care recipients to ensure the adequacy of care, protect the well-being of caregivers, and prevent the costs of informal care from spilling over to other sectors of the economy.</p>","PeriodicalId":22450,"journal":{"name":"The European Journal of Health Economics","volume":"81 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138575357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Patient-reported experience is associated with higher future revenue and lower costs of hospitals","authors":"Alice Giese, Rasheda Khanam, Son Nghiem, Thomas Rosemann, Michael M. Havranek","doi":"10.1007/s10198-023-01646-y","DOIUrl":"https://doi.org/10.1007/s10198-023-01646-y","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Background</h3><p>Despite the established positive association between patient experience and patient volume, the relationship between patient experience and the financial performance of hospitals has not been studied thoroughly.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>To investigate this relationship, we used longitudinal data from 132 Swiss acute-care hospitals from 2016 to 2019 to examine the associations between patient experience and the proportion of elective patients, revenue, costs, and profits of hospitals. To account for a potential time lag effect, we utilized annual patient experience data and employed multilevel mixed-effects regression modeling to investigate its association with the aforementioned financial performance indicators for the following year.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>Data for private and public hospitals were analyzed both separately and in combination, to account for the different proportions of elective patients in these types of hospitals. The resulting mixed models, revealed that for each year studied, the previous year’s patient experience was positively associated with the current year’s proportion of elective patients (β = 0.09, <i>p</i> = 0.004, all hospitals) and revenue (β = 1789.83, <i>p</i> = 0.037, private hospitals only), and negatively associated with costs (β = − 1191.13, <i>p</i> = 0.017, all hospitals); but not significantly associated with future profits (β = 629.12, <i>p</i> = 0.240, all hospitals).</p><h3 data-test=\"abstract-sub-heading\">Conclusions</h3><p>This analysis showed that better patient experience is associated with a higher proportion of elective patients, greater revenue, and lower costs. Our findings may assist hospital managers and regulators in identifying strategies to increase revenue and reduce costs.</p>","PeriodicalId":22450,"journal":{"name":"The European Journal of Health Economics","volume":"2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138559759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Are costs derived from diagnosis-related groups suitable for use in economic evaluations? A comparison across nine European countries in the European Healthcare and Social Cost Database.","authors":"Zuzana Špacírová, David Epstein, Jaime Espín","doi":"10.1007/s10198-022-01444-y","DOIUrl":"10.1007/s10198-022-01444-y","url":null,"abstract":"<p><strong>Background: </strong>Economic evaluation of health technologies requires healthcare resources, procedures and services to be valued at their opportunity cost. In practice, many economic evaluation studies use official databases of hospital Diagnosis-Related Groups (DRGs) as inputs where unit costs are required. This study describes the available data on costs of hospital DRG from official, publicly available sources in nine European countries (England, France, Germany, Italy, Poland, Portugal, Slovenia, Spain and Sweden), critically examines and compares the methodologies used to construct these databases and comments on the appropriateness of such unit cost data for economic evaluation.</p><p><strong>Methods: </strong>A standardized semi-structured questionnaire was developed in order to obtain both official publicly available sources of inpatient DRG databases and documents explaining the costing methodology used in calculation of unit costs available in those databases.</p><p><strong>Results: </strong>England stands out as a benchmark in terms of good practice. Other countries face more challenges in one or more items, whether in documenting and auditing processes, guaranteeing methodological rigour, including all relevant economic items such as depreciation of buildings and equipment and capital costs, conducting the process annually and completely, publishing the costs as well as tariffs and recognising sampling uncertainty or variation.</p><p><strong>Conclusion: </strong>Analysts should evaluate carefully whether DRG costs or tariffs published in each country are appropriate for use in economic evaluation.</p>","PeriodicalId":22450,"journal":{"name":"The European Journal of Health Economics","volume":"1 1","pages":"1563-1575"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89496079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A comprehensive review of official discount rates in guidelines of health economic evaluations over time: the trends and roots.","authors":"Elahe Khorasani, Majid Davari, Abbas Kebriaeezadeh, Farshad Fatemi, Ali Akbari Sari, Vida Varahrami","doi":"10.1007/s10198-022-01445-x","DOIUrl":"10.1007/s10198-022-01445-x","url":null,"abstract":"<p><strong>Background: </strong>The question of discounting in health economics is anything but settled, so much so that a section of the Health Technology Assessment (HTA) guidelines is devoted to it.</p><p><strong>Objective: </strong>This study aimed to review the trend of the value of the official discount rates (DRs) of costs and health outcomes and their roots worldwide.</p><p><strong>Methods: </strong>Four methods were combined to identify official DRs over time globally. These methods included a systematic review of the HTA/pharmacoeconomic/health economic evaluation guidelines, a review of methodological documents or guidelines accessible on the websites of HTA organizations, and two separated reviews of the websites of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and the Guide to Health Economic Analysis and Research (GEAR).</p><p><strong>Results: </strong>Our systematic search eventually yielded 339 documents from the literature, 35 links from the website of the HTA organizations, 51 documents from the website of the ISPOR, and 29 documents from the website of the GEAR. These documents referred to 48 countries over 30 years and 43 transnational guidelines over 43 years. DRs of 3% and 5% had the most frequent value. Among them, 38 countries always used an equal DR of costs and health outcomes. We categorized the rationales for selecting DRs into eight groups for the national documents and six groups for the transnational documents.</p><p><strong>Conclusion: </strong>The comparability approach was the most frequent rationale for choosing the DR in national and transnational guidelines. The value of DR of costs and health outcomes ranged from zero to 10% over the years, but the most common values were 3% and 5%, mainly arising from the comparability approach chosen. Several transnational guidelines have suggested a specific DR without taking into account countries' economic conditions. It is useful to establish a specific guideline for calculating and updating the DR of the health sector in each country.</p>","PeriodicalId":22450,"journal":{"name":"The European Journal of Health Economics","volume":"18 1","pages":"1577-1590"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87897281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"European union regulation of health technology assessment: what is required for it to succeed?","authors":"Michael Drummond, Rosanna Tarricone, Aleksandra Torbica","doi":"10.1007/s10198-022-01458-6","DOIUrl":"10.1007/s10198-022-01458-6","url":null,"abstract":"","PeriodicalId":22450,"journal":{"name":"The European Journal of Health Economics","volume":"30 1","pages":"913-915"},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81329075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Seeking efficiency gains outside drugs and diagnostics.","authors":"Reyes Lorente, Fernando Antonanzas","doi":"10.1007/s10198-022-01456-8","DOIUrl":"10.1007/s10198-022-01456-8","url":null,"abstract":"","PeriodicalId":22450,"journal":{"name":"The European Journal of Health Economics","volume":"22 1","pages":"759-761"},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87450601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Reply to comment on “Demonstrating the value of cancer biomarkers at the population”","authors":"Ana Beatriz D’Avó Luís, Mikyung Kelly Seo","doi":"10.1007/s10198-022-01475-5","DOIUrl":"https://doi.org/10.1007/s10198-022-01475-5","url":null,"abstract":"","PeriodicalId":22450,"journal":{"name":"The European Journal of Health Economics","volume":"55 1","pages":"757-758"},"PeriodicalIF":0.0,"publicationDate":"2022-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86470984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Demonstrating the value of cancer biomarkers at the population level","authors":"A. Gandjour","doi":"10.1007/s10198-022-01474-6","DOIUrl":"https://doi.org/10.1007/s10198-022-01474-6","url":null,"abstract":"","PeriodicalId":22450,"journal":{"name":"The European Journal of Health Economics","volume":"41 1","pages":"755 - 756"},"PeriodicalIF":0.0,"publicationDate":"2022-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81410179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The attractiveness of jobs in the German care sector: results of a factorial survey","authors":"Martin Kroczek, Jochen Andreas Späth","doi":"10.1007/s10198-022-01443-z","DOIUrl":"https://doi.org/10.1007/s10198-022-01443-z","url":null,"abstract":"","PeriodicalId":22450,"journal":{"name":"The European Journal of Health Economics","volume":"102 1","pages":"1547 - 1562"},"PeriodicalIF":0.0,"publicationDate":"2022-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78061633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Looking into the black box of “Medical Innovation”: rising health expenditures by illness type","authors":"F. Breyer, Normann Lorenz, G. Pruckner, T. Schober","doi":"10.1007/s10198-022-01447-9","DOIUrl":"https://doi.org/10.1007/s10198-022-01447-9","url":null,"abstract":"","PeriodicalId":22450,"journal":{"name":"The European Journal of Health Economics","volume":"195 1","pages":"1601 - 1612"},"PeriodicalIF":0.0,"publicationDate":"2022-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87061743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}